Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for Gossamer Bio (GOSS) over the last 3 years, with Q3 2025 value amounting to $7.5 million.

  • Gossamer Bio's Other Operating Expenses changed N/A to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 2524.0%. This contributed to the annual value of $10.0 million for FY2023, which is 1528461.54% up from last year.
  • Per Gossamer Bio's latest filing, its Other Operating Expenses stood at $7.5 million for Q3 2025.
  • Gossamer Bio's Other Operating Expenses' 5-year high stood at $10.0 million during Q4 2023, with a 5-year trough of $15000.0 in Q2 2022.
  • Over the past 3 years, Gossamer Bio's median Other Operating Expenses value was $15000.0 (recorded in 2022), while the average stood at $2.2 million.
  • Within the past 5 years, the most significant YoY rise in Gossamer Bio's Other Operating Expenses was 6656666.67% (2023), while the steepest drop was 2500.0% (2023).
  • Quarter analysis of 3 years shows Gossamer Bio's Other Operating Expenses stood at $15000.0 in 2022, then surged by 66566.67% to $10.0 million in 2023, then dropped by 25.24% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $10.0 million for Q4 2023, and $15000.0 during Q2 2023.